S. 2062 · 119th Congress (2025–2027)
RAPID Reserve Act
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 2062’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Gary C. Peters (D-MI)
- Cosponsors
3 cosponsors
3 original · 0 later
- Sen. Marsha Blackburn (R-TN)· Original · Jun 12, 2025
- Sen. Ted Budd (R-NC)· Original · Jun 12, 2025
- Sen. Tim Kaine (D-VA)· Original · Jun 12, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (3)
RAPID Reserve Act
Display title, Short title · Introduced in Senate
Rolling Active Pharmaceutical Ingredient and Drug Reserve Act
Short title · Introduced in Senate
A bill to improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
Official title · Introduced in Senate